Mohan Prasad
Aravind Eye Hospital
194 Papers
661 Citations
Mohan Prasad is an academic researcher from Aravind Eye Hospital. The author has contributed to research in topics: Vilazodone & Malic acid. The author has an hindex of 12, co-authored 194 publications.
Chat about Author
Papers
Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part II: INASL Recommendations for Management of HCV in India
Pankaj Puri,Anil C. Anand,Vivek A. Saraswat,Subrat K. Acharya,Shiv Kumar Sarin,Radha K. Dhiman,Rakesh Aggarwal,Shivaram Prasad Singh,Deepak Amarapurkar,Anil Arora,Mohinish Chhabra,Kamal Chetri,Gourdas Choudhuri,Vinod Kumar Dixit,Ajay Duseja,Ajay K. Jain,Dharmesh Kapoor,Premashis Kar,Abraham Koshy,Ashok Kumar,Kaushal Madan,Sri Prakash Misra,Mohan Prasad,Aabha Nagral,Amarendra S. Puri,R. Jeyamani,Sanjiv Saigal,Samir Shah,Praveen Sharma,Ajit Sood,Sandeep Thareja,Manav Wadhawan +31 more
TL;DR: It may be prudent to withhold treatment at present for selected patients with genotype 1 or 4 infection and low levels of fibrosis (F1 or F2), and for patients who are non-responders to initial therapy, interferon intolerant, those with decompensated liver disease, and patients in special populations.
29
Patent
Crystalline form of baricitinib
Gyanendra Pandey,Javeena,Kaptan Singh,Mohan Prasad +3 more
- 29 Apr 2015
TL;DR: In this article, a crystalline form of baricitinib, a process for its preparation, a pharmaceutical composition comprising it, and its use for the treatment of JAK-associated diseases.
20
Patent
Crystalline cefdinir potassium dihydrate
Yatendra Kumar,Mohan Prasad,Ashok Prasad,Shailendra Kumar Singh,Neela Praveen Kumar +4 more
- 12 Dec 2002
TL;DR: In this article, the present invention relates to a novel crystalline cefdinir potassium dihydrate, to a process for its preparation and to a method of preparing pure cefinir via the crystalline salt.
18
Sofosbuvir plus ribavirin in treatment-naïve patients with chronic hepatitis C virus genotype 1 or 3 infection in India.
Samir Shah,Abhijit Chowdhury,R. Mehta,Dharmesh Kapoor,Ajay Duseja,Abraham Koshy,Akash Shukla,Ajit Sood,Kaushal Madan,Randhir Sud,Sandeep Nijhawan,R. Pawan,Mohan Prasad,K. Kersey,Deyuan Jiang,Evguenia S. Svarovskaia,Brian P. Doehle,B. Kanwar,Mani Subramanian,Subrat K. Acharya,Shiv Kumar Sarin +20 more
TL;DR: Overall, sofosbuvir plus ribavirin therapy achieved SVR12 rates ≥90% and was well tolerated among treatment‐naïve patients with chronic genotype 1 or 3 HCV infection in India.
17
Patent
Conversion of aromatic nitriles into tetrazoles
Yatendra Kumar,Kintali Venkata Ramana,Mohan Prasad,Asok Nath,Swargam Sathyanarayana,Bakthavathsalan Vijayaraghavan +5 more
- 23 Nov 2004
TL;DR: In this article, the conversion of aromatic nitriles to tetrazoles is described, comprising treatment of the cyano compound with trialkyltin chloride and sodium azide optionally in the presence of a phase transfer catalyst.
15